4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-417970
CEO acquired 23,564 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Weis Holger CEO | 2026-10-06 | Grant or award | +23,564 | $0.74 | $17,541 | 49,047 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…